Neumora Therapeutics, Inc. (NMRA) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$206.44M | -12.8% |
| 2024 | -$182.94M | -12.0% |
| 2023 | -$163.28M | -42.1% |
| 2022 | -$114.90M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$206.44M | -12.8% |
| 2024 | -$182.94M | -12.0% |
| 2023 | -$163.28M | -42.1% |
| 2022 | -$114.90M | — |